Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-04-10
2007-04-10
Saeed, Kamal A. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S273000, C514S275000, C514S278000, C514S367000, C514S370000, C514S375000, C514S389000, C514S392000, C544S230000, C546S015000, C546S017000, C548S147000, C548S216000, C548S301100
Reexamination Certificate
active
10549338
ABSTRACT:
The present invention is directed to compounds of the formula:that are antagonists of CGRP receptors and that are useful in the treatment or prevention of diseases in which the CGRP is involved, such as headache, migraine and cluster headache. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which CGRP is involved.
REFERENCES:
patent: 6548505 (2003-04-01), Martin et al.
Pinder et al. J. Med. Chem. 1971, 14(9), 893-893. * indicates the CAS Abstract and Structures are attached.
Bell Ian M.
Gallicchio Steven N.
Stump Craig
Theberge Cory R.
Zartman C. Blair
Merck & Co. , Inc.
Nolan Jason M.
Rose David L.
Rubin David
Saeed Kamal A.
LandOfFree
Bicyclic anilide spirohydantoin CGRP receptor antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Bicyclic anilide spirohydantoin CGRP receptor antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Bicyclic anilide spirohydantoin CGRP receptor antagonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3720747